News
The company will use the funds to expand its presence globally and enhance its platform.
The tech giant says the feature lets users check their blood pressure on the wrist, but it requires calibration with a cuff every 28 days.
The company will use the funds to expand its agentic AI platform and fund new models for employers, including access to GLP-1 medications.
The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across multiple therapeutic areas.
Jussi Vasama, CEO of Digital Workforce, discusses the Finnish company's partnership with a U.S. health system and its plans to further grow in the market.
The AI decision-support system, trained on multimodal ophthalmic data, will assist in diagnosis, treatment planning, and disease monitoring and management.
Dr. Bill Fera, principal at Deloitte, highlights the importance of human oversight in healthcare AI and shares his insights on the next big innovations in the sector.
AI revenue cycle management platform Adonis raises $40 million and Blossom Health, a telehealth platform for psychiatry, garners $20 million.
It will be based on an AI model that achieved high accuracy in predicting liver metastasis using patients' routine blood tests.
Also, Zydus has introduced two AI-enabled CGM devices in India.